Loading clinical trials...

U-LABA/ICS Effects on Exercise Performance, Indacaterol | Clinical Trials | Clareo Health

RECRUITINGNA

U-LABA/ICS Effects on Exercise Performance, Indacaterol

Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Indacaterol

NCT06067100•Morten Hostrup, PhD

Summary

The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist indacaterol + mometasonefuroate

Eligibility

Age

18 - 39 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18-39
•Physically active \> 5 h weekly
•Maximal oxygen consumption classified as high or very high

Exclusion Criteria

•Diagnosed with severe asthma and been in treatment with long-acting beta2-agonist/corticosteroid
•ECG abnormality
•ACQ score \> 1.5
•Severe bronchial hyperreactivity as determined by mannitol test
•FEV1/FVC ratio \< 0.7 determined with spirometry
•Chronic illness determined to be a potential risk for participant during study
•In chronic treatment with medication that may interfere with study results
•Pregnancy
•Smoker
•Blood donation during the past 3 months

Locations (1)

August Krogh Building

Copenhagen, Denmark

Key Dates

Start Date

January 15, 2024

Primary Completion Date

July 15, 2026

Completion Date

December 1, 2026

Last Updated

April 9, 2025

Enrollment

ESTIMATED participants

Conditions

Exercise Performance

Interventions

Indacaterol and Mometasonefluroate (low dose)

DRUG

Placebo

DRUG

Indacaterol and Mometasonefluroate (high dose)

DRUG

Contacts

Morten Hostrup, PhD

CONTACT

+4535321595 mhostrup@nexs.ku.dk

Submaximal Cardiopulmonary Exercise Testing for Detection of Myocardial Injury After Noncardiac Surgery

NCT06474754

Myocardial Injury After Non-cardiac SurgerySubmaximal Exercise Performance+1 more

View study

RECRUITINGPHASE2/PHASE3

Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes

NCT07252778

Sports NutritionBiochemical Markers+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

U-LABA/ICS Effects on Exercise Performance, Indacaterol

Inclusion Criteria

Exclusion Criteria

Submaximal Cardiopulmonary Exercise Testing for Detection of Myocardial Injury After Noncardiac Surgery

Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes

HIIT Effects on Table Tennis Players

Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation

The Effect of Acute Beetroot Juice Supplementation on Anaerobic Performance in Football Players

Effects of Taurine Supplementation on Repetitive Sprint Performance and Exhaustion Time in College Students Under High-Temperature and High-Humidity Conditions